REGN Live signals | Maximize Profits with Getagraph.com

SELL 4681 min ago

@ $1 050.86

Issued: 28 Jun 2024 @ 13:47

Return: 0.59%

Previous signal: Jun 27 - 11:56

Previous signal: Buy

Return: 0.02 %

Live Chart Being Loaded With Signals

Commentary (1 Jul 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 0.95% compare to its pairs and should correct upwards.

Stats
Today's Volume	369 380
Average Volume	460 553
Market Cap	114.55B
EPS	$6.70 ( Q1 \| 2024-05-02 )
Next earnings date	( $10.57 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	31.23 (Sector) 42.63 (Industry) 24.32
ATR14	$24.69 (2.34%)

AADI -2.74%

ABCL -6.08%

ABCM 0.04%

ABEO -0.94%

ABIO -0.78%

ABOS -1.45%

ABSI -2.27%

ABUS 0.97%

ABVX 2.57%

ACAD -1.29%

ACER -17.95%

ACET -4.96%

ACGN 1.29%

ACHL -1.60%

ACHV 1.70%

ACIU -0.25%

ACLX -2.88%

ACRV 1.03%

ACST -2.34%

ACXP -4.89%

ADAG -0.33%

ADAP 7.70%

ADGI 0.87%

ADIL -5.22%

ADMA 3.31%

ADPT -0.55%

ADTX 14.49%

ADVM 1.60%

ADXN -12.26%

AEON -0.95%

AEZS 3.07%

AFMD -0.73%

AGEN -0.36%

AGIO 0.60%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -2.51%

AKRO -1.28%

AKTX 15.23%

AKUS 0.00%

ALBO 0.00%

ALDX -1.81%

ALEC -2.64%

ALGS 5.43%

ALKS 1.20%

ALLK -12.02%

ALLO 0.00%

ALLR 6.44%

ALNA 3.16%

ALNY 0.13%

ALPN 0.02%

ALPX 0.00%

ALRN 1.08%

ALT 8.27%

ALVR 0.93%

ALXN 0.00%

ALXO -0.66%

ALZN 0.91%

AMRN -0.29%

AMTI -3.13%

ANAB -1.80%

ANEB -1.83%

ANGN 0.00%

ANIX 0.45%

ANL -6.05%

ANNX 3.06%

ANPC -3.15%

APGE -1.96%

APGN 8.48%

APGNW 30.65%

APLM 0.96%

APLS -5.40%

APLT -1.28%

APM -7.51%

APOP 0.38%

APRE -0.98%

APTO -1.51%

APTX 3.17%

APVO 9.15%

ARAV -13.39%

ARCT -2.83%

ARDS 19.76%

ARDX 2.16%

ARGX 0.97%

ARNA 0.00%

ARPO -0.90%

ARQT 2.80%

ARTL -3.57%

ARTLW 0.00%

ARVN -2.40%

ARWR 0.23%

ASLN 0.00%

ASMB -3.50%

ASND -1.76%

ATAI 1.50%

ATHA -5.28%

ATHE 0.00%

ATHX -33.50%

ATNF -7.98%

ATOS 0.84%

ATRA -1.65%

ATXI -2.86%

ATXS 1.65%

AUPH -3.85%

AURA -2.51%

AUTL -0.29%

AVBP -2.16%

AVEO 0.00%

AVIR 1.81%

AVRO -1.41%

AVTE 2.41%

AVTX 1.12%

AVXL -2.61%

AXLA 0.00%

AXSM 0.66%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO -0.51%

BCAB -1.46%

BCDA 0.67%

BCDAW 0.00%

BCEL 0.00%

BCLI 5.47%

BCRX 7.93%

BCTX -4.39%

BCTXW 17.17%

BCYC 0.25%

BDRX -0.23%

BDTX 0.86%

BEAM -1.62%

BFRA -2.91%

BGNE 1.56%

BIOR -4.56%

BIVI 4.00%

BLCM -6.68%

BLI -5.88%

BLPH -1.93%

BLRX -1.06%

BLTE 0.31%

BLU 0.03%

BLUE -0.90%

BMEA -1.78%

BMRN -0.24%

BNOX -10.04%

BNTC 3.92%

BNTX -1.90%

BOLD 8.27%

BOLT -2.41%

BPMC 1.30%

BPTH -3.00%

BPTS -13.47%

BRNS 2.14%

BRTX -2.46%

BTAI -8.59%

BTTX -15.97%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 2.92%

CABA 4.41%

CADL 1.61%

CALA 0.00%

CALC 7.32%

CALT -0.62%

CAPR 1.47%

CARA 1.94%

CARM 9.87%

CASI -1.82%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -5.89%

CCCC 4.98%

CCXI 0.00%

CDAK 0.00%

CDIO -1.82%

CDIOW 6.00%

CDMO -0.28%

CDMOP 0.04%

CDT -6.12%

CDTTW 72.08%

CDTX 0.84%

CDXC -1.47%

CDXS -3.55%

CELC 1.59%

CELU 1.92%

CELUW 1.32%

CERC -1.68%

CERE 1.13%

CERO -8.16%

CEROW 43.57%

CFRX -27.95%

CGEM -4.07%

CGEN 4.17%

CGON 0.48%

CGTX 0.60%

CHMA -6.00%

CHRS -6.94%

CINC 0.00%

CING 7.50%

CINGW 4.85%

CKPT -4.65%

CLBS -16.75%

CLDX 5.35%

CLGN 1.00%

CLLS 3.48%

CLNN 0.22%

CLNNW 44.05%

CLRB 2.00%

CLSD -4.62%

CLSN -0.68%

CLVS 0.00%

CMMB 5.00%

CMND -1.19%

CMPI 0.00%

CMPX -5.45%

CMRA 0.00%

CMRAW 33.33%

CMRX -0.80%

CNCE 0.00%

CNSP -10.13%

CNST 0.00%

CNTA -2.55%

CNTB -5.26%

CNTX -9.73%

COCP 3.00%

COEPW 0.00%

COGT 6.05%

CORT 0.55%

COYA 0.66%

CPRX 1.81%

CRBP 9.17%

CRBU -3.05%

CRDF -7.66%

CRGX -2.56%

CRIS -7.54%

CRNX 2.86%

CRSP -0.11%

CRTX 2.63%

CRVO -5.84%

CRVS 1.65%

CSBR -4.26%

CTCX 23.31%

CTIC 0.06%

CTMX 9.02%

CTNM 19.25%

CTXR -6.92%

CUE -17.74%

CVAC -2.06%

CVKD -1.15%

CWBR 0.00%

CYAD -12.96%

CYCC 0.00%

CYCCP -11.68%

CYCN 0.88%

CYT -2.27%

CYTK 0.96%

CYTO 9.91%

DARE -6.03%

DAWN -1.45%

DBTX -0.81%

DBVT 2.20%

DFFN 10.28%

DICE 0.06%

DMAC 0.00%

DNLI -5.21%

DNTH 11.55%

DOMH 4.81%

DRMA -5.37%

DRMAW 7.69%

DRNA 0.00%

DRTS 0.79%

DRTSW 19.05%

DRUG -2.77%

DSGN -2.99%

DTIL 1.64%

DYAI 3.38%

EARS -1.77%

EDIT -1.28%

EDSA 2.09%

EFTR -8.00%

EFTRW -41.67%

EIGR -9.21%

ELAB 0.07%

ELDN -4.92%

ELEV 5.93%

ELOX 1.45%

ELTX -8.03%

ELVN -2.87%

ELYM -0.84%

ENGN -4.03%

ENGNW -2.88%

ENLV -2.82%

ENOB 1.79%

ENSC -1.23%

ENTA 0.77%

ENTO -11.11%

ENTX -4.35%

ENVB -5.90%

EPIX -2.66%

EPRX 2.38%

EPZM 0.00%

EQ -2.21%

EQRX -2.09%

EQRXW 0.00%

ERAS 3.39%

ERNA 4.14%

ERYP 1.30%

ESLA 4.76%

ESLAW 0.00%

ETNB -3.12%

ETON 3.34%

ETTX 0.00%

EVAX 0.70%

EVGN -0.91%

EVLO 39 899.32%

EWTX 7.61%

EXAI 0.98%

EXEL -0.98%

EYEG -0.51%

EYEN 14.27%

EYPT -4.48%

FATE -0.61%

FBIO -1.17%

FBIOP 0.70%

FBLG -19.84%

FBRX 1.68%

FDMT 1.67%

FENC 2.62%

FGEN -13.69%

FHTX 1.57%

FIXX 0.77%

FMTX 0.00%

FNCH -10.95%

FOLD -1.21%

FREQ 4.76%

FRLN 0.15%

FRTX -4.21%

FSTX 0.00%

FTRE 2.23%

FULC 1.77%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT 3.98%

GANX -12.50%

GBIO -8.87%

GBT 0.01%

GDTC -0.99%

GERN 2.36%

GHRS 0.77%

GLMD -1.01%

GLPG 0.93%

GLSI -2.84%

GLTO -1.73%

GLUE 5.35%

GLYC 5.15%

GMAB -1.11%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT 10.80%

GNLX -5.64%

GNPX 2.39%

GNTA -0.87%

GOSS 5.18%

GOVX 2.98%

GOVXW -10.37%

GPCR 1.86%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -6.13%

GRTX -8.63%

GTHX 8.33%

GUTS 4.45%

GXGXW 41.67%

GYRE 0.92%

HALO -0.65%

HARP 0.09%

HCWB 0.46%

HEPA -0.93%

HGEN -84.62%

HILS 5.66%

HLVX -0.28%

HOOK 6.17%

HOTH -1.12%

HOWL -3.69%

HRMY 0.83%

HRTX -0.86%

HSTO 0.00%

HUMA 11.88%

HUMAW 22.30%

IBRX -0.79%

ICCC -8.04%

ICPT 0.21%

ICU 23.06%

ICUCW 13.26%

ICVX -0.91%

IDRA -23.04%

IDYA 2.31%

IFRX -1.72%

IGMS -1.16%

IKNA 0.00%

IKT -5.34%

IMAB -2.99%

IMCR 7.49%

IMGN 0.02%

IMGO 0.00%

IMMP 0.00%

IMMX 7.07%

IMNM 0.83%

IMNN 8.62%

IMPL -27.27%

IMRA 15.96%

IMRN -9.26%

IMRX -8.59%

IMTX 3.27%

IMTXW 27.41%

IMUX 0.90%

IMV 0.00%

IMVT 4.20%

INAB -3.95%

INBX -3.03%

INCY 0.41%

INDP 4.25%

INFI -52.38%

INKT -3.51%

INM -5.24%

INMB -4.54%

INO 6.56%

INSM -0.99%

INTS 0.41%

INVA 0.61%

INZY -1.12%

IOBT -4.27%

IONS -1.15%

IOVA 0.50%

IPA -3.71%

IPHA 7.22%

IPSC -5.49%

IRON 3.11%

ISEE 0.38%

ITOS 1.15%

ITRM -5.60%

IVA -1.19%

IVVD 9.09%

JAGX -2.79%

JANX -0.41%

JAZZ -0.24%

JNCE 0.00%

JSPR 1.94%

JSPRW 5.15%

JUNS 0.00%

JUNSW 0.00%

KA 4.20%

KALV 0.93%

KDNY 0.22%

KMPH -0.34%

KNSA -3.59%

KNTE -0.38%

KOD 0.85%

KPRX 3.57%

KPTI -6.01%

KRBP -1.83%

KRON -9.68%

KROS -4.22%

KRRO -0.06%

KRTX 0.03%

KRYS -0.75%

KTRA 10.14%

KTTA 0.38%

KTTAW 1.83%

KURA 2.96%

KYMR 3.69%

KYTX 4.13%

KZIA -4.91%

KZR -2.73%

LABP 0.57%

LBPH 14.39%

LBPS 0.00%

LBPSW 14.81%

LEGN 3.91%

LENZ 2.31%

LEXX -0.72%

LEXXW 23.90%

LGND 0.70%

LGNDV 0.00%

LGVN -2.48%

LIAN -8.28%

LIFE 2.70%

LIPO -3.41%

LIXT -0.38%

LIXTW -3.71%

LJPC -0.32%

LMNL 0.12%

LOGC -3.15%

LPCN -6.31%

LPTX -4.59%

LQDA 0.33%

LRMR 13.66%

LSTA 2.31%

LTRN -3.21%

LUMO -2.46%

LVTX 3.89%

LXEO -2.68%

LXRX -0.30%

LYEL 8.97%

LYRA 7.30%

MACK 0.10%

MBIO 2.41%

MBRX -1.15%

MCRB -0.25%

MDGL -0.30%

MDNA -13.16%

MDWD -0.84%

MDXG -3.32%

MEIP -2.06%

MESO -0.44%

MGNX 1.18%

MGTA -7.74%

MGTX -2.61%

MGX 8.33%

MIRM -0.09%

MIRO 0.59%

MIST 0.75%

MITO 0.00%

MLEC -0.88%

MLECW -31.50%

MLND -5.36%

MLTX -4.94%

MLYS 4.02%

MNKD -2.49%

MNMD -1.94%

MNOV 0.00%

MNPR -0.88%

MOLN 2.80%

MOR -0.22%

MORF -4.46%

MREO 0.83%

MRKR -0.74%

MRNA -2.36%

MRNS 9.40%

MRSN -1.99%

MRTX -0.17%

MRUS -7.98%

MRVI -3.07%

MTCR -1.29%

MTEM 2.61%

MTP -18.50%

MURA -0.96%

MYMD 0.00%

NAMS 7.13%

NAMSW -4.76%

NAUT -2.99%

NBRV 0.71%

NBSE -1.56%

NBTX 7.00%

NCNA 7.36%

NERV -0.86%

NEXI -6.90%

NGM -1.28%

NGNE 11.62%

NKGN 0.00%

NKGNW -12.00%

NKTR -1.61%

NKTX -1.02%

NLSP -9.50%

NLSPW 26.58%

NMRA 1.12%

NMTR -42.97%

NOVN -24.84%

NRBO -6.20%

NRIX 0.19%

NRSN -3.57%

NRSNW -2.91%

NRXP 5.74%

NRXPW 41.43%

NRXS 1.44%

NTBL -6.12%

NTEC -12.45%

NTHI 0.00%

NTLA 0.40%

NTRBW 74.65%

NUVL -0.46%

NVAX 0.55%

NVCT -2.37%

NVIV -34.28%

NXTC -5.66%

NYMX -0.05%

OABI -0.27%

OABIW -9.28%

OBIO -12.64%

OBSV 0.00%

OCEA -3.28%

OCGN 4.84%

OCS -0.50%

OCUL -2.63%

OCUP 3.92%

ODT -4.27%

OKYO 1.64%

OLMA 2.96%

OMER -2.71%

OMGA 8.70%

ONCO -6.10%

ONCR -3.08%

ONCS 31.87%

ONCT -7.70%

ONCY 0.53%

ONTX -0.47%

ONVO -0.34%

OPNT 0.00%

OPT -0.99%

ORGS 8.13%

ORIC 8.06%

ORMP -0.39%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK 0.41%

OVID 12.09%

OYST 0.00%

PALI -5.29%

PASG 11.43%

PBLA -10.00%

PBM 6.33%

PBYI 0.61%

PCSA -7.11%

PCVX 1.89%

PDSB 3.41%

PEPG 12.22%

PGEN -1.90%

PHAR -4.62%

PHAS 0.00%

PHAT 4.95%

PHIO -3.88%

PHIOW 36.47%

PHVS -0.59%

PHXM -5.20%

PIRS -1.82%

PKBO 0.00%

PKBOW 999 900.00%

PLRX 1.02%

PLUR -0.43%

PMN 6.67%

PMVP -2.47%

PNT 0.16%

PPBT -13.47%

PRAX -0.41%

PRDS 0.93%

PRLD -1.05%

PROG -3.47%

PROK 1.63%

PRQR -0.60%

PRTA -0.78%

PRTC 3.68%

PRTG -7.63%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV 2.04%

PSTX 3.08%

PTCT 1.93%

PTE -0.82%

PTGX 1.59%

PTIXW -48.41%

PULM 1.55%

PXMD -1.27%

PYPD -0.24%

PYXS -3.32%

QLGN -3.77%

QNCX -3.33%

QNRX 1.75%

QSI -11.01%

QSIAW 4.08%

QTTB 5.74%

QURE -0.78%

RAIN -1.63%

RANI 0.53%

RAPT -5.57%

RARE 0.05%

RCKT -4.04%

REGN 0.57%

RENB -10.86%

REPL 4.00%

RETA 0.02%

REUN -0.89%

REVB -1.58%

REVBU 3.46%

REVBW 0.00%

RGLS 6.44%

RGNX -5.38%

RIGL 2.31%

RLAY -1.84%

RLMD 2.33%

RLYB 1.49%

RNA 1.05%

RNAC -10.14%

RNAZ -4.54%

RNXT 1.77%

ROIV 2.46%

ROIVW 4.56%

RPHM 2.65%

RPRX -0.68%

RPTX 0.91%

RUBY 2.70%

RVLP -32.05%

RVMD 0.00%

RVMDW -1.40%

RVNC 0.00%

RVPH -7.03%

RVPHW 4.88%

RXDX 0.09%

RXRX -0.53%

RYTM 3.92%

RYZB 0.02%

RZLT 0.23%

SABS -1.94%

SABSW 54.57%

SAGE 1.57%

SANA 0.18%

SAVA -1.70%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 3.16%

SCPH -0.69%

SCPS 0.00%

SEEL 3.69%

SEER 0.60%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -7.90%

SGMT -7.60%

SGTX -2.56%

SIOX 22.63%

SLDB 10.58%

SLGL -4.21%

SLN -1.37%

SLNO 3.65%

SLRX -7.92%

SLS -0.84%

SMMT 4.36%

SNDX 4.87%

SNGX -4.26%

SNPX 1.97%

SONN -0.80%

SPPI -0.49%

SPRB 2.55%

SPRC -5.98%

SPRO -1.54%

SRNE -20.00%

SRPT -0.79%

SRRA 0.00%

SRRK -2.40%

SRZN -2.28%

STAB 0.00%

STOK 2.66%

STRO 4.10%

STSA 0.00%

STTK 3.37%

SURF -0.93%

SVRA 15.14%

SWTX 2.28%

SYBX -0.67%

SYRS -4.46%

TALS -0.73%

TARA 0.48%

TARS 3.90%

TBPH 0.47%

TCBP 1.76%

TCDA 0.00%

TCON -30.63%

TCRR 0.00%

TCRT -6.87%

TCRX 1.37%

TECH -0.06%

TENX -1.32%

TERN 0.59%

TFFP 7.23%

TGTX 2.02%

THRX 0.12%

TIL 0.10%

TLC 0.00%

TLSA -3.63%

TNGX 4.90%

TNXP 4.96%

TNYA 8.71%

TPST -2.28%

TRDA 0.49%

TRVI -3.02%

TRVN -3.81%

TSHA 0.89%

TSVT 5.19%

TTNP -0.18%

TVTX 0.73%

TYRA 8.07%

UBX -1.48%

UNCY 7.76%

URGN -1.79%

UTHR 0.14%

VACC 11.36%

VALN -3.27%

VAXX 20.24%

VBIV 4.85%

VBLT -8.77%

VCEL -1.85%

VCNX -0.15%

VCYT -1.57%

VERA 0.30%

VERU 4.45%

VERV 2.05%

VIGL 9.25%

VINC -6.26%

VIR 2.25%

VIRI 3.26%

VIRX -6.20%

VKTX 4.36%

VLON -13.04%

VNDA -1.24%

VOR -1.07%

VRCA 9.05%

VRDN 1.54%

VRNA 7.26%

VRPX -1.59%

VRTX 0.54%

VSTM 9.06%

VTGN 2.59%

VTVT -0.42%

VTYX -2.16%

VXRT 3.19%

VYGR -0.63%

VYNE -2.54%

VYNT 7.78%

WINT 0.00%

WVE 4.91%

XBIO -0.48%

XBIT 7.98%

XCUR -3.93%

XENE -3.33%

XERS -3.56%

XFOR 1.62%

XLO -2.49%

XLRN 0.00%

XNCR 0.48%

XOMA 5.11%

XOMAO 0.20%

XOMAP 1.98%

XRTX -1.06%

YMAB -2.07%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -0.23%

ZNTL 2.45%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-24	Bassler Bonnie L	Sell	756	Non-Qualified Stock Option (right to buy)
2024-06-24	Bassler Bonnie L	Buy	756	Common Stock
2024-06-24	Bassler Bonnie L	Sell	756	Common Stock
2024-06-24	Larosa Joseph J	Buy	14 450	Common Stock
2024-06-24	Larosa Joseph J	Sell	11 084	Common Stock

INSIDER POWER
-42.51
Last 100 transactions
Buy: 261 982 \| Sell: 649 170

Correlation (AI algo v.1.1b): Undervalued: 0.95% $1 067.46 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: 0.73 (moderate)

Short: 0.54 (weak)

Signal:(67) Neutral

Regeneron Pharmaceuticals Correlation

10 Most Positive Correlations
KPLT	0.823

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Regeneron Pharmaceuticals Correlation - Currency/Commodity

-0.65
( weak negative )

-0.66
( moderate negative )

-0.73
( moderate negative )

-0.11
( neutral )

0.40
( neutral )

-0.37
( neutral )

Regeneron Pharmaceuticals Financials

Annual	2023
Revenue:	$13.12B
Gross Profit:	$11.30B (86.16 %)
EPS:	$37.05

FY	2023
Revenue:	$13.12B
Gross Profit:	$11.30B (86.16 %)
EPS:	$37.05

FY	2022
Revenue:	$12.17B
Gross Profit:	$10.61B (87.18 %)
EPS:	$40.51

FY	2021
Revenue:	$16.07B
Gross Profit:	$13.63B (84.83 %)
EPS:	$76.40

Financial Reports:

Symbol	Period	Year	Title
REGN	Q4	2023	Financial Report for REGN - Q4 2023

Regeneron Pharmaceuticals Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma;Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration and license agreements with Sanofi; Bayer; Teva Pharmaceutical Industries Ltd.; Mitsubishi Tanabe Pharma Corporation; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Kiniksa Pharmaceuticals, Ltd., as well as has an agreement with the U.S. Department of Health and Human Services, as well as with Zai Lab Limited; Intellia Therapeutics, Inc.; Biomedical Advanced Research Development Authority; and AstraZeneca PLC. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.